AML: Expert Guidance on Current Standards and New Directions in Patient Care

In this program experts discuss how to identify patients using molecular and cytogenetic testing to optimally select recently approved agents to improve patient outcomes. Watch the on-demand Webcast download the slides from a dynamic CCO symposium in Orlando and access a downloadable summary resource.

Share

Program Content

No activities added yet

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Actinium

Boston Biomedical

Jazz Pharmaceuticals, Inc.

Pfizer, Inc.

Partners

NCCN

ProCE Banner